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Background: Given that we know that interventions shown to be effective in improving the health of a population
may actually widen the health inequalities gap while others reduce it, it is imperative that all systematic reviewers
consider how the findings of their reviews may impact (reduce or increase) on the health inequality gap. This study
reviewed existing guidance on incorporating considerations of health inequalities in systematic reviews in order to
examine the extent to which they can help reviewers to incorporate such issues.
Methods: A mapping review was undertaken to identify guidance documents that purported to inform reviewers
on whether and how to incorporate considerations of health inequalities. Searches were undertaken in Medline,
CINAHL and The Cochrane Library Methodology Register. Review guidance manuals prepared by international
organisations engaged in undertaking systematic reviews, and their associated websites were scanned. Studies
were included if they provided an overview or discussed the development and testing of guidance for dealing with
the incorporation of considerations of health inequalities in evidence synthesis. Results are summarised in narrative
and tabular forms.
Results: Twenty guidance documents published between 2009 and 2016 were included. Guidance has been
produced to inform considerations of health inequalities at different stages of the systematic review process. The
Campbell and Cochrane Equity Group have been instrumental in developing and promoting such guidance.
Definitions of health inequalities and guidance differed across the included studies. All but one guidance document
were transparent in their method of production. Formal methods of evaluation were reported for six guidance
documents. Most of the guidance was operationalised in the form of examples taken from published systematic
reviews. The number of guidance items to operationalise ranges from 3 up to 26 with a considerable overlap
noted.
Conclusions: Adhering to the guidance will require more work for the reviewers. It requires a deeper
understanding of how reviewers can operationalise the guidance taking into consideration the barriers and
facilitators involved. This has implications not only for understanding the usefulness and burden of the guidance
but also for the uptake of guidance and its ultimate goal of improving health inequalities considerations in
systematic reviews.
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Background
Health inequalities are avoidable and unjust differences
in health between individuals or populations [1]. Given
that we know that interventions shown to be effective in
improving the health of a population may actually widen
the health inequalities gap while others reduce it, it is
imperative that systematic reviewers consider how the
findings of their reviews may impact (reduce or increase)
the health inequality gap [2–4]. Furthermore, the exist-
ence of social inequalities, defined as “systematic differ-
ences in health between different socioeconomic groups
within a society” (1, p. 473, [5]), increases the argument
for all reviewers, not just those with a focus on health
inequalities (HI), to consider the potential for their find-
ings to reduce or increase HI. This is echoed by
Cochrane and Campbell Collaborations who have called
for the effects of interventions on HI to be considered
by systematic review authors [6, 7].
Incorporating considerations of how review findings
impact on health inequalities also aims to overcome one
of the major barriers in using systematic reviews to in-
form decision-making, policy-making and practice [8].
Moving away from simply assessing what works to consid-
ering how review findings impact on disadvantaged popu-
lations, by assessing for example differential effects by
subgroup populations can improve the applicability of the
review findings to the local population[9, 10] thus increas-
ing their fit for purpose in supporting decision-making
and practice. Going beyond simply does it work to exam-
ine under what circumstances it works for whom and why
[11] holds even more resonance when considering the im-
pact on HI. As O’Neill et al. ([12], p. 57) point out, “the
intervention has to be accessible, acceptable, effective in,
and used by the most disadvantaged group within that
population to be truly effective at reducing inequities in
health” (whilst health inequalities are defined as avoidable
differences in health outcomes across individuals or
between populations, the narrower but related term
health equity is often referred to in the literature as
health inequalities which are also considered unfair
and unjust [13].)
Methodological research has highlighted an absence of
evidence with regards to the extent to which systematic
reviews taking into account issues of HI when analysing
and making recommendations for further research and
practice [3, 14, 15]. Furthermore, recent methodological
studies of systematic reviews demonstrated that very few
(<5%) addressed differential impacts across socio-
economic groups [16, 17]. The extent to which system-
atic reviewers in the past have failed to consider how
their review findings impact on HI, is due in part to the
focus reviewers placed on the effectiveness of interven-
tions and also due to a lack of relevant data reported in
the primary literature to assess such differential effects
[18]. In addition, the lack of guidance or awareness of
the existence of such guidance in this area may also have
worsened the situation. More importantly, however, it is
also due to a failure on the part of review authors to
even consider differential impacts in reviews where HI is
not the focus [8, 17, 19].
This paper aims to review existing guidance on incorp-
orating considerations of HI in systematic reviews to
examine the extent to which they can help reviewers in-
corporate such considerations in systematic reviews.
Aim and objectives
The aim of this study was to undertake a mapping re-
view of existing guidance documents currently provided
to assist reviewers when determining whether and how
to incorporate considerations of HI. A mapping review
aims to map out and categorise the literature according
to key features (e.g. study design) on a particular topic
and to identify gaps in the research literature [20]. The
objectives were (1) to provide an overview on the types
of guidance, in particular the focus, scope and purpose
of the guidance, (2) to explore how the guidance is
defined by authors, (3) to describe the methods used to
develop the guidance, (4) to examine the comprehen-
siveness, overlap and operationalisation of the guidance.
Search strategy
A systematic approach to identifying the literature was
undertaken in a two-tiered approach. Firstly, more gen-
eric guidelines to evidence synthesis were located and
searched to identify specific guidance relating to the in-
corporation of HI. A search of review guidance manuals
prepared by international organisations engaged in
undertaking evidence synthesis was undertaken (see
Table 1). Publications listed on the Campbell and
Cochrane Equity Group website were also scanned.
In addition to this, a search was undertaken in Med-
line, CINAHL and The Cochrane Methodology Register.
Key terms searched on included thesaurus and text-
words terms comprising of synonyms for health inequal-
ities, evidence synthesis and methodology/guidance/
Table 1 International evidence synthesis organisation websites
Agency for Healthcare Research and Quality (www.ahrq.gov)
The Cochrane Collaboration (www.cochrane.org)
The Campbell and Cochrane Equity Methods Group (http://
methods.cochrane.org/equity/)
Centre for Reviews and Dissemination at the University of York
(http://www.york.ac.uk/crd/)
EPPI-Centre (http://eppi.ioe.ac.uk/)
Health Technology Assessments (http://www.nets.nihr.ac.uk/
programmes/hta)
European Network for Health Technology Assessments (EUnetHTA –
http://www.eunethta.eu/)
National Institute for Health and Care Excellence (NICE –
www.nice.org.uk)
Joanna Briggs (http://joannabriggs.org/sumari.html)
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tools (see Appendix 1). A pre-published search strategy
designed to capture HI studies was reviewed and utilised
[21]. A practical approach to developing a search strat-
egy to identify different types of evidence synthesis was
adopted. This approach was informed by published sys-
tematic review filters and related evidence synthesis
terms (e.g. realist review, realist synthesis, integrative).
Searches were undertaken in September 2015, and
search alerts were set up to capture relevant articles
added into the databases after this date. No restrictions
by year were applied, but publications were limited to
English language only studies.
Requests for guidance were made via relevant email
discussion lists and contacting experts in the Campbell
and Cochrane Equity Group. For guidance that had been
updated, the most recent update was included. Where
multiple publications discuss the same guidance they
were considered together.
Inclusion criteria
Any type of study was included if it provided an over-
view or discussed the development and testing of a con-
ceptual or practical framework, tool, model or guidance
(advice or formal recommendations) for dealing with the
incorporation of considerations of HI in evidence syn-
thesis. For the purpose of this review, HI is defined ac-
cording to Whitehead’s ([1], p. 473) definition in which
inequalities in the British context—and increasingly also
across Europe—carries the same connotations of unfair-
ness and injustice as the term inequities. Both generic
guidance (e.g. guidelines published by evidence synthesis
organisations or collaborations) that incorporated con-
siderations of HI and HI-specific guidance (e.g. scholarly
methodological studies presenting specific guidance for
incorporating considerations of HI in systematic re-
views) were included. Studies that primarily offer a the-
oretical discussion or comments on if and why HI
should be included in evidence synthesis, or frameworks
and guidance for the incorporation of HI for purposes
other than evidence synthesis, were excluded. For prac-
tical reasons, studies were limited to English language
publications. Screening of studies was undertaken by the
author.
Data extraction
Data were extracted by the author on targeted audience
(e.g. for reviewers, users of evidence synthesis), purpose
(e.g. tools are to be used for planning, conducting,
reporting, disseminating or using systematic reviews),
scope (e.g. to inform systematic reviews, other research),
how the tool was developed, operationalisation of the
tool (how reviewers are instructed to apply the guidance)
and whether and how they define health inequalities. In-
cluded studies were also categorised as to their focus, i.e.
whether they were HI, or had a generic focus but which
accounted for HI.
Data synthesis
Results are summarised in narrative and tabular forms.
Strengths and weaknesses of the guidance in assisting
systematic reviewers were assessed based on methods of
development including evaluation, accessibility and
transparency in operationalisation.
Results
The results of the search are summarised in Fig. 1. Eight
hundred and thirty-six references were identified of
which 20 were included in the review. All guidance doc-
uments [12, 22–40] incorporating considerations of HI
in systematic reviews were published between 2009 and
2016. Table 2 outlines the characteristics of the included
studies. Doull et al. [22] report on three guidance docu-
ments within the same study [23–25]. Tugwell et al. [29]
and Ueffing et al. [30] both discuss the Cochrane Equity
Checklist, whilst Welch et al. [32, 33] and Burford et al.
[34] report on the PRISMA-Equity 2012 Extension. The
majority of the guidance has been produced with the in-
volvement of members of the Campbell and Cochrane
Equity Methods Group.
Focus, scope and purpose of guidance
Table 2 outlines the focus, scope and purpose of the
guidance. The majority of the guidance documents have
Fig. 1 Flow of search results
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Table 2 Characteristics of included studies













Armstrong et al. [37]a ✓ ✓ ✓ ✓ ✓ ✓
Armstrong et al. [38]a ✓ ✓ ✓ ✓ ✓ ✓
Chambers and Wilson [39] ✓ ✓ ✓ ✓ ✓
CRD [40] ✓ ✓ ✓ ✓ ✓
Doull et al. [22]b ✓e ✓ ✓ ✓ ✓ ✓ ✓
Doull et al. (25)b ✓e ✓ ✓ ✓ ✓ ✓ ✓
Puil et al. [24]b ✓e ✓ ✓ ✓ ✓ ✓ ✓
Welch et al. [23]b ✓e ✓ ✓ ✓ ✓ ✓ ✓
NIHR CLAHRC North West Coast
[26]
✓f ✓ ✓ ✓g ✓ ✓ ✓ ✓
Nasser et al. [27] ✓ ✓ ✓ ✓ ✓
O’Neill et al. [12] ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓
Oxman et al. [28] ✓ ✓ ✓ ✓ ✓ ✓
Tugwell et al. [29]c ✓ ✓ ✓ ✓ ✓ ✓ ✓
Ueffing E et al. [30]c ✓ ✓ ✓ ✓ ✓ ✓ ✓
Tugwell et al. [31] ✓ ✓ ✓ ✓ ✓
Welch et al. [32]d ✓ ✓ ✓ ✓ ✓ ✓ ✓
Welch et al. [33]d ✓ ✓ ✓ ✓ ✓ ✓ ✓
Burford et al. [34]d ✓ ✓ ✓ ✓ ✓ ✓ ✓
Welch et al. [35] ✓e,f ✓ ✓ ✓ ✓ ✓h
Welch et al. [36] ✓ ✓ ✓ ✓ ✓ ✓ ✓
aGuidance from the Cochrane Collaboration
bDoull et al. [22] report on three guidance documents [23–25] within the same study
cReport on the Cochrane Equity Checklist [29]
dReport on the PRISMA-Equity 2012 Extension [32]
eSex and gender focus
fSocioeconomic focus
gApplied research, evidence synthesis, capacity building and knowledge exchange and implementation












an HI focus; three focus on sex and gender [23–25], one
on socio-economic status (SES) [26] and one on both
sex and SES analysis in systematic reviews [35] All four
generic guidance documents in which HI was consid-
ered, signposted reviewers onto HI-focused guidance
produced by the Campbell and Cochrane Equity Group
or the PROGRESS framework [12]. All guidance were
produced for informing the production of systematic re-
views with two guidance documents also applicable to
other types of research [12, 26]. Guidance has been pro-
duced to inform considerations of HI at different stages
of the systematic review process with the most guidance
produced to support the conduct of systematic reviews.
Guidance definitions
The documents defined their guidance in different ways,
for example, as briefing notes [22–25] equity lens
[12, 26, 27, 29, 30], recommendations [29, 30, 36],
plausibility algorithm [35], tool [28] framework [31, 39],
guidance [37, 38, 40] and guidelines [32–34].
All but three guidance documents [31, 39, 40] define
what is meant by HI, equity or inequity. Where defini-
tions are recorded, they differed across the studies.
Whitehead’s [13] definition of health equity and HI were
the most commonly reported within the guidance docu-
ments, although a number of different authors were
cited for HI [8, 13, 41, 42], health inequity [13, 41, 43]
and health equity [13, 44–48]. Four of the five guidance
documents with a sex and gender HI focus all define what
it meant by sex and gender in the same way [22–25]. Nei-
ther of the two guidance documents with a socio-
economic focus define socio-economic status [26, 35].
Development of guidance
Table 3 outlines the guidance development process of
the included studies. The majority of the guidance docu-
ments were transparent in outlining how the guidance
had been produced. Of those reporting methods of guid-
ance development, all were informed by a literature
review.
The guidance development process for most in-
volved seeking feedback and revision from people
with a wide range of expertise (including researchers,
HI experts, review methodologists, decision-makers,
clinical epidemiologists, practitioners and journal edi-
tors) and systematic review experience, the majority
of whom were either members of the Cochrane Col-
laboration or were attending Cochrane Workshops.
Burford et al. [34] and Doull et al. [22] specifically re-
port involving novice reviewers in the development of
their guidance. The PRISMA-E 2012 reporting guide-
lines [32, 33] were also informed by consensus
methods. Whilst all of the guidance documents were
produced from an HI perspective, only five had
theoretical underpinnings or followed established methods
in developing their guidance [22, 27, 32, 33, 35].
Operationalisation of guidance
As a means of demonstrating what reviewers should
consider in the application of the items, most of the
guidance provide examples from published systematic
reviews. For example, when asking reviewers to consider
whether there are known or possible differences by sex/
gender, Welch et al. [23] use the following example, “In
a systematic review on quality of life after total hip and
total knee arthroplasty, men appeared to benefit more
from the intervention in the few studies that addressed
this issue.”
Despite the different purposes and audiences, there is
a considerable overlap in what users of the guidance are
asked to consider at different stages of the review
process. Table 4 highlights this using the example of
whether to expect differential effects across SES popula-
tion characteristics.
The rationale for why HI should be considered was
also provided in some guidance. For example, Oxman et
al. ([28], “Questions to consider”, no.3) ask “are there
likely to be different baseline conditions across groups
or settings such that the absolute effectiveness of the op-
tion would be different, and the problem more or less
important, for disadvantaged groups or settings?” They
then outline the rationale, “Typically, baseline risks are
larger in disadvantaged populations and a larger absolute
effect could therefore be expected.” ([28], “Questions to
consider”, no.3).
When addressing how reviewers can operationalise the
items, the comprehensiveness and application with
which this is detailed differs across the guidance. For ex-
ample, the number of items reviewers are asked to con-
sider in the guidance documents ranges from 3 up to 26.
Many guidance documents recommend using a theory-
based approach, using programme theory or logic
models to understand the assumptions behind how and
why the intervention may work differently across disad-
vantaged populations and the influence of context on
the outcome [22–26, 29, 30, 32, 33, 35, 36]. However,
there is a lack of detail on how this could be imple-
mented in practice. Tugwell et al. ([29], 2.“Defining dis-
advantage”, para. 2), for example, state that “implications
on inequities are dependent on context, so authors of HI
orientated reviews must strive to understand and explore
the mediating effect of context”, yet they do not define
what is meant by context and what data could be
collected to explore this. Welch et al. [32] suggest that
one limitation of the guidance is the use of terminology
such as logic model, analytic framework, context and
process evaluation, terms that are not widely accepted. A
lack of consistency was noted in applying such terms
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Table 3 Development of guidance
Guidance Aim/audience Development method Operationalisation Strengths/limitations
HI-focused guidance
Doull et al. [22]
Welch V., et al. for the sex/
gender methods group.
[23]
Puil L., et al. for the sex/
gender methods group.
[24]
Doull M., et al. for the sex/
gender methods group.
[25]
To translate knowledge about
sex/gender analysis into a
user-friendly briefing note
format and evaluate its use in
aiding in the implementation
of sex/gender analysis in
systematic reviews.
Aimed at reviewers and





• Informed by literature reviews
•Built on existing structured
guidance for systematic
reviewers
• Feedback and revision
sought
• Evaluated by 19
participants attending a
workshop at the 2012
Canadian Cochrane
Symposium
• Underpinned by diffusion
of innovations theory
Who else was involved:











Sections 1–3 define the
issue, definitions and
rationale for considering sex
and gender analysis.
Section 4 has 13 items to





study design; searching for
studies; data collection; risk

















• Piloted and evaluated
Open access
Limitations:




model, context) may not be
widely accepted or
understood
NIHR CLAHRC North West
Coast [26]
To help ensure that all
activities of the NIHR
CLAHRC NWC have
potential to contribute to
reducing health inequalities.
Aimed specifically at anyone
undertaking CLAHRC NWC
work (including reviewers)
but also anyone wishing to
consider HI in their research
Guidance development
process:
Collaborative process in a
series of workshops in 2014/
2015
Who was involved:
NIHR CLAHRC NWC staff and
partners
Four sections:
1. Clarifying the health





monitoring the impact of
your activity




Each section also includes a
Health Inequalities
Assessment of an exemplar
proposal for applied
research.
Links to resources that
provide more information
about the issues covered in
each section.
Guidance provided on how
to use HIAT.
Strengths:
• Revised after feedback
from users, plan to revise
regularly after further user
feedback. encourages









• Limited information on
how the guidance was
developed or tested.
• Long checklist
• Worked example is not a
systematic review




O’Neill et al. [12] To assess the utility of an





social capital (“PROGRESS”) to
guide the conceptualization of
disadvantage, data extraction,







for the PRISMA Equity
Extension, can be applied to
systematic reviews
Asks reviewers to consider
variations in health across 8





status and social capital.
For each PROGRESS factor,
examples are provided that
demonstrate differences in
burden of disease and an
effective intervention that
could reduce that burden.
Strengths:
• Considers multiple equity
dimensions
Limitations:
• Limited examples provided





• Not open access
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Table 3 Development of guidance (Continued)
Nasser et al. [27] To develop and pilot an
equity lens to help
researchers develop a more
equity-oriented approach
toward priority setting and




• A workshop presenting
survey results from a
previous project
• Literature review
• Workshop for refinement






15 people attending the
2008 Cochrane Colloquium
attended the first workshop,





1. 9 questions assessing
priority setting, from
identifying the questions
and stakeholders to the
evaluation strategy.






• Evaluated by a self-
selecting group attending
Cochrane Meeting
• Not open access
Oxman et al. [28] To present a structured
approach to considering the




options to implement and
how to implement them.
Aimed at users











• No information available
on how the guidance was
developed or evaluated.
• Terminology used may not
be widely accepted or
understood
• Greater detail required on
how reviewers can
operationalise the items
Tugwell et al. [29]
Ueffing E, et al. for the
Campbell and Cochrane
Equity Methods Group. [30]
To provide guidance on
assessing equity for users
and authors of systematic
reviews of interventions.
Aimed at reviewers, users
and journal editors.
Development process:
• 4 working sessions
• Built on previous work by




• Panel members reviewed
the evidence and drafted
guidance









reviews, experts in public
health and health equity,
experts from low and
middle income countries
and policy advisers who use
systematic reviews.
Members of the Campbell
and Cochrane Equity













•Addition of resources to
signpost reviewers to
sources of help when
attempting to answer the
questions.
Limitations:
• Terminology used may not
be widely accepted or
understood
• Greater detail required on
how reviewers can
operationalise the items
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Table 3 Development of guidance (Continued)
Tugwell et al. [31] “Propose an evidence based



















• No information available
on how the guidance was
developed or tested.
• Does not define equity
Welch et al. [32]
Welch et al. [33]




results for equity focused
reviews. To legitimise and
emphasize the importance









• Reviewing the literature
(systematic review and
methodological study)




















14-item equity extension of





available, an exemplar for
recommending each item
and examples of good
practice.
Strengths:
• Wide range of expertise
involved in development
• Involved non-expert re-
viewers in development
• Consensus-based










• Terminology used may not
be widely accepted or
understood
• Greater detail required on
how reviewers can
operationalise some items,
e.g. approach to logic
model
Welch et al. [35] To develop and assess
inter-rater agreement for
an algorithm for systematic
review authors to predict
whether differences in effect









• Review of existing
guidance
• Systematic review of
methods for assessing
effects on health equity
• Survey of practitioners/
managers







users of SRs assessed the
algorithm against a pre-










how each of the questions
may result in differential
effects
Strengths:











• Low inter-rater reliability
• Tested by individuals





• Subject expertise of the
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Table 3 Development of guidance (Continued)




of PRISMA-E 2012 to facilitate
the use of both guidance
documents. This article also
discusses challenges related





• Series of methodology
meetings
• Systematic review of
methods to assess equity
in systematic reviews
• Methods study













10 steps to considering
health equity in reviews.
Recommendations with a
few brief examples from
exemplar reviews
Strengths:







• Terminology used may not
be widely accepted or
understood




Armstrong R, Waters E,
Doyle J (editors) [37]
Chapter 21: Reviews in
health promotion and
public health. In Higgins





Elizabeth Waters on behalf















Chambers and Wilson [39] To enable researchers to
present and contextualize
evidence from systematic




Uses the Oxman et al. [28]
criteria
4b Strengths:
• As above for Oxman et al.
[28]
• Authors offer advice on
operationalising guidance




or relevant to the NHS,




As above for Oxman et al. [28]










aSignposts reviewers to The Campbell and Cochrane Equity Methods Group
bFollows tools developed by SUPPORT collaboration [28]
cSignposts reviewers to PROGRESS and The Campbell and Cochrane Equity Methods Group
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across the guidance with some referring instead to
causal pathway analysis, program theory and mecha-
nisms of action.
Few guidance documents discuss who should be in-
volved in making decisions on if and how HIs matter in
systematic reviews. Tugwell et al. [29] suggest that rele-
vant stakeholders should be involved in defining the re-
view question, whilst HIAT [26] recommend involving
members of the public (e.g. service users, carers, people
living in disadvantaged neighbourhoods) in the planning
stages. Only Welch et al. [35] started to explore how
people came to their decisions of whether to expect dif-
ferential effects across sex/SES and found that these de-
cisions were made based on theory, personal experience,
empirical data and guesses, but called for further re-
search to investigate how these are used to make
judgements.
Evaluation of guidance
Formal methods of evaluation were reported in three
studies [22, 34, 35] for six of the guidance documents
[23–25, 32, 33, 35]. Burford et al. [34] surveyed 151 sys-
tematic review authors on the perceived utility of the
PRISMA-E 2012 [32, 33]. Reported advantages of using
PRISMA-E 2012 include improved awareness of HI con-
siderations in systematic reviews and improved
consistency of reporting of HI in systematic reviews.
Barriers reported include time required to apply guid-
ance, length of guidance, increase length and complexity
of reviews and lack of data in primary studies to oper-
ationalise some of the guidance.
Doull et al. [22] undertook a workshop evaluation
involving 19 participants including potential users
(researchers, practitioners and policy-makers) with little
or some knowledge of the concepts of sex/gender to
evaluate the content, readability and comprehensiveness
of their briefing notes [23–25]. Although respondents
reported that the briefing notes “provided clear meth-
odological guidance to address sex/gender in reviews”
([22], Results, para. 2) and rated all aspects highly, re-
sponses were mixed on the level of complexity within
the methods section.
Finally, in Welch et al. [35] four clinical methodolo-
gists evaluated the face and construct validity of a plausi-
bility algorithm in predicting the likelihood of
differential effects across sex and SES. Thirty-five review
users, methodologists and clinicians also assessed the
inter-rater reliability of the algorithm against ten pre-
selected systematic reviews. The results found a low to
no agreement beyond chance between raters for each of
the three questions across sex and socioeconomic con-
siderations. The authors suggest several reasons for the
poor agreement relating to the design of the algorithm
(use of multi-component questions covering several fac-
tors, omission of a don’t know category for responses),
individual characteristics of respondents and poor choice
of proxy or gold standard set of reviews to test the algo-
rithm against. Whether any of the guidance has resulted
in an uptake of considerations of HI in systematic re-
views is still to be determined [22, 33].
Discussion
This review identified 20 guidance documents for in-
corporating considerations of equity in systematic re-
views spanning the whole spectrum of the review
process, from planning, conduct and reporting through
to considerations of applicability to disadvantaged popu-
lations and knowledge translation when using reviews to
Table 4 Overlap of guidance items on anticipating differential effects across SES in relation to population characteristics
Guidance Purpose Item (i.e. what reviewers are asked to consider)
Can we expect differential effects across socioeconomic status in relation to population characteristics?
Welch et al. [36, p. 2] Conduct
Knowledge
translation
Define conceptual approach to health equity “whether social gradients exist in the burden of disease and
whether relative or absolute effects of interventions are likely to differ for disadvantaged populations”
Frame the health equity question “This requires consideration of both relative risk and absolute effects, as
well as baseline risk of the health outcome of interest across social gradients.”
Welch et al. [35] Planning “Are there differences in patient/community/population characteristics (e.g. underlying pathophysiology,
comorbidities, patient attitudes, etc.) that are likely to create important differences in the magnitude of
relative effect of the intervention versus the control for the outcome of interest?”
Oxman et al. [28] Applicability “Which groups or settings are likely to be disadvantaged in relation to the option being considered?”
“Are there plausible reasons for anticipating differences in the relative effectiveness of the option for
disadvantaged groups or settings?”
“Are there likely to be different baseline conditions across groups or settings such that that the absolute
effectiveness of the option would be different, and the problem more or less important, for
disadvantaged groups or settings?”
NIHR CLAHRC North
West Coast [26]
Planning “What evidence is there that this problem is unequally distributed across socio-economic groups?”
“What aspects of socio-economic inequalities can be expected to impact on this problem?”
Welch et al. [23] Planning
Conduct
Question formulation: “Consider whether there are known or possible differences by sex/gender across:
baseline risk, prevalence, vulnerability, implementation or response to intervention, and plan objectives
and methods accordingly.”
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inform decision-making and policy. Many of the docu-
ments have been published in the last 3 years, highlight-
ing the fact that methodological research in this field is
an important, emerging and evolving area of interest.
The majority of the guidance is published in open access
format in the journal literature. Whilst this increases the
accessibility of the guidance, omission from standard re-
view guidance handbooks places a greater emphasis on
guidance authors to raise awareness of the existence of
such tools to encourage greater uptake. For example,
Welch et al. [32, 33] recognise the importance of wide-
spread dissemination amongst journal editors, funding
bodies and ethics committees in order to encourage the
adoption of the PRISMA-Equity 2012 Extension report-
ing guideline.
Increasing awareness of such guidance is even more
important when reviewers are faced with the different
terminology used by authors to describe it. Use of mul-
tiple terms such as algorithm, equity lens, tool, may
make them harder to locate within the journal literature.
The Campbell and Cochrane Equity Methods Group
have started to collate guidance on HI considerations for
review authors [49], yet the list does not cover all guid-
ance identified in this review and focuses to a greater ex-
tent on the guidance developed to support Cochrane
Review authors.
Whitehead’s [13] definition of HI as “Inequality in
health is a term commonly used in some countries to in-
dicate systematic, avoidable and important differences”
and health inequity as “refers to differences in health
which are not only unnecessary and avoidable but, in
addition, are considered unfair and unjust” were most
commonly applied in the guidance. However, rather than
demonstrate an acceptance of a common definition for
HI or health equity, most of the guidance citing
Whitehead [13] were produced by the same group (The
Campbell and Cochrane Equity Methods Group). The
different definitions of HI and health equity used by the
guidance documents supports the view by Tugwell et al.
[29] that these terms are used in different ways by differ-
ent authors, and that there is no agreed definition of
health equity or HI. This stresses the importance there-
fore for HI guidance to define health equity and/or HI
to help reviewers to operationalise the guidance.
This is particularly true for guidance incorporating
considerations of SES in systematic reviews. Neither
of the two guidance documents with a focus on SES
[26, 35] defined the term. Several of the guidance
documents refer reviewers to the PROGRESS frame-
work [12, 50] when asking reviewers to consider dis-
advantage. PROGRESS although does not explicitly
define SES, relates it to income, while considering
education and occupation separately. Yet SES has
been defined more broadly as “a composite measure
that typically incorporates economic status, measured
by income, social status, measured by education; and
work status measured by occupation” ([51], pp. 30),
[52, 53]. The classification of individuals by SES has
implications for reviewers in relation to types of SES
indicators to collect and therefore, the definition and
classification of HI terms such as SES needs to be
operationalised within the guidance. This is further
supported by the findings of Runnels et al. [54] who
in a survey examining the challenges of including
sex/gender analysis in systematic reviews found that
one of the significant challenges was clarifying the
concepts of sex and gender.
Much of the guidance is written from the perspective of
HI having already being identified as the focus of the re-
view and from a whole HI perspective rather than focusing
on a specific HI dimension. More recently, however, guid-
ance is being tailored more towards specific HI domains, in
particular, sex/gender [23–25, 35] and SES [26, 35]. This
may reflect the interests of the groups involved in produ-
cing the guidance. For example, HIAT [26] was developed
by the National Institute of Health Research Collaboration
for Leadership in Applied Health Research and Care North
West Coast (NIHR CLAHRC NWC) whose remit is to en-
sure that all of the research it produces has socio-economic
relation to HI as its core focus (www.hiat.org.uk).
Guidance on incorporating sex/gender analysis in sys-
tematic reviews was produced by the Cochrane Sex/
Gender Methods Group (a subgroup of the Campbell
and Cochrane Equity Methods Group). However, the de-
velopment of more HI-specific guidance may also sug-
gest that once reviewers have identified which HI
domain(s) to consider, they may have difficulty operatio-
nalising the more generic HI-focused tools and require
more tailored guidance. Or it may be that given that it
would be impossible for reviewers to incorporate consid-
erations across all HI dimensions, that there is a debate
developing that certain HI domains may be considered
more important than others to incorporate in systematic
reviews. Indeed, in the application of the PROGRESS
framework to systematic reviews, O’Neill et al. [12, p.
62] state that the framework is “not intended to encour-
age data dredging but to identify the most important fac-
tors that drive inequities in health”.
The Campbell and Cochrane Equity Group have been
instrumental in driving forward methodological ad-
vances in evidence synthesis for the incorporation of HI
in systematic reviews, and although not specifically
stated, most of the guidance produced appears most
relevant to reviewers undertaking systematic reviews
measuring the effectiveness of interventions or at users
assessing the applicability of reviews of effectiveness.
This is no doubt partly due to the focus of the Cochrane
Collaboration on reviews of effectiveness, yet how well
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this guidance translates to other types of HI systematic
reviews (e.g. qualitative) therefore is unclear, and further
research investigating the usefulness of the guidance for
other types of reviews is required.
One potential challenge facing reviewers in operatio-
nalising the guidance is that methodological approaches
to incorporating considerations of HI are still in devel-
opment, and even the guidance authors themselves rec-
ognise that one of the limitations of the guidance may
relate to the terminology used, such as logic model,
process evaluation, mechanisms of action, terms which
may not be accepted [32] or understood [55]. Encour-
aging reviewers to consider what works for disadvan-
taged populations, why, how and under what
circumstances not only requires as Tugwell et al. ([29],
Conclusions, para. 2) suggest “a paradigm shift in the
generation and synthesis of evidence”, but also an ac-
ceptance of the terminology along with an understand-
ing of how these methods can be applied in practice.
Part of the problem is that current review methods can-
not necessarily be transferred across to consider more
complex issues and HI [3, 11] and methods to incorpor-
ate such complexity in systematic reviews are only just
emerging [9, 11, 56–61]. Given the potential complexity
of the process therefore, further research examining the
challenges and barriers in incorporating considerations
of HI in systematic reviews is required to better support
reviewers in undertaking HI-focused reviews.
There is also perhaps, a greater need to understand
how guidance items can be operationalised. Most of the
guidance is operationalised by means of descriptive ex-
amples from published systematic reviews, and there is
evidence to indicate that reviewers find them useful. For
example, Doull et al., [22] in testing their guidance on
incorporating issues of sex/gender analysis in systematic
reviews found that reviewers wanted even more
examples.
Much of the guidance is written with an underlying
assumption that reviewers will recognise if and how
equity matters. Empirical evidence however suggests
otherwise [35, 54]. A recent survey by Runnels et al. [54]
conducted on the challenges of including sex/gender
analysis in systematic reviews seems to support this
view. They found that concerns were raised over the
construction of knowledge and cites one respondent say-
ing “the biggest challenges are much more fundamental
and have to do with the way that we arrive at decisions
as to what is important for us to study, why it is import-
ant for us to study, and how we determine the way to
study” ([53], Conceptual challenges, para. 3).
Welch et al., [35] in developing their equity plausibility
algorithm, start to explore the rationale behind re-
viewers’ decisions and found that empirical data, theory
or personal experience were often used to explain their
reasons but call for further research to enhance under-
standing of how this was used and the contribution of
individual characteristics to the process. In order to help
reviewers to operationalise the guidance therefore, it
may be useful to explore the rationale behind how re-
viewers are making decisions when applying the guid-
ance and the contribution made to those decisions by
different individuals (e.g. stakeholders).
Furthermore, if, as Welch et al. ([35], Discussion, para.
1) suggest, reviewers “need to have a deep understanding
of the content area” to make judgements about likely
differential effects, then single examples drawn from
topic-specific reviews may not be the best way to dem-
onstrate guidance application. Without a comprehensive
understanding of the different ways in which HI issues
may contribute towards differential effects in health out-
comes, it may be difficult for some reviewers, particu-
larly those new to HI, to recognise the need to
incorporate or operationalise such issues in systematic
reviews. Building on this, research is currently underway
by the author (MM) to identify a comprehensive set of
considerations to help reviewers operationalise the influ-
ence of socio-economic contextual factors on how and
why an intervention may work differently across disad-
vantaged populations.
Strengths of the guidance evaluation methods in-
clude the involvement of a wide range of expertise
(e.g. reviewers, methodologists, decision-makers, HI
experts), consensus methods and piloting of the guid-
ance. However, the use of self-selecting samples may
not necessarily be representative of the wider popula-
tion expected to utilise the guidance. Assessment of
face validity alone, i.e. a subjective assessment of the
relevance of the questions [62] rather than evaluating
how well the guidance works when applied prospect-
ively may not identify problems operationalising
items. Burford et al. [34] used a prospective design to
assess the utility of the reporting guidelines but,
largely due to the type of guidance, did not ask re-
viewers to discuss how they had operationalised the
checklist items. In addition, evaluation of the guid-
ance appears to be undertaken by individuals rather
than reflecting the collaborative approach that a sys-
tematic review encourages. This may be a further rea-
son why the Welch et al. [35] plausibility algorithm
had poor inter-rater reliability. Evaluating guidance
using a case study approach, may better capture how
well the guidance is interpreted or operationalised by
those it is designed to assist. Involving novice re-
viewers in the guidance evaluation may also identify
challenges in interpreting and operationalising the
guidance that may not necessarily be considered when
piloting is undertaken by the guidance developers or
expert reviewers alone.
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Strengths and limitations of the review
This study is the first to summarise the range of guid-
ance available on the incorporation of HI in systematic
reviews. One of the strengths of this study is detailing
what guidance is available for considering HI at various
stages of the systematic review process. There is no vali-
dated search filter for HI, however, terms were based on
those used in a Cochrane methodological review explor-
ing how effects on HI are assessed in systematic reviews
[21]. The review did not seek to critique the individual
items/questions in the guidance or recommend one
guidance over another, but rather offer an overview of
guidance available to reviewers when incorporating con-
siderations of HI at different stages of the review
process.
A potential limitation of this review is that as this
study is part of a PhD study, only one person was in-
volved in the selection of studies, data extraction and
synthesis. One limitation of this review is the focus on
English language literature when it is acknowledged that
other languages, such as Spanish, may offer extensive
coverage of literature regarding inequalities. As this is
not a systematic review, the search was restricted to a
small number of key databases in health, further data-
bases outside of health could have been searched. In-
stead, a targeted approach to the search was adopted
using a number of different search approaches, including
scanning of relevant systematic review organisational
websites, reference checking and contacting known ex-
perts in the field. Given the diverse nature of the guid-
ance documents included in this review, no formal
quality appraisal was undertaken instead each guidance
document was assessed as to whether or not it formally
evaluated.
Conclusions
Given the recent growing interest in the incorporation
of HI in systematic reviews, it is not surprising that
methodological guidance exploring how considerations
of HI can be incorporated into evidence synthesis is a
relatively new and emerging area of research [7, 36].
Above all, the strength of all the guidance documents
reviewed in this study is in highlighting the importance
of incorporating considerations of HI in systematic re-
views, yet due to the fairly recent introduction of the
guidance there is little evidence on the guidance uptake
or whether it has led to an improvement in consider-
ations of HI in systematic reviews. It is clear, however,
that operationalising the guidance will require more
work for the reviewer but aside from the Runnels et al.
[54] survey, there is limited evidence on the challenges
facing reviewers when incorporating considerations of
HI. Furthermore, understanding how reviewers can op-
erationalise the guidance and the challenges in doing so
have implications not only for understanding the useful-
ness and burden of the guidance [34], but also has impli-
cations for the uptake of guidance and its ultimate goal
of improving HI considerations in systematic reviews.
There is currently a gap in the evidence examining how
reviewers can operationalise the guidance and the bar-
riers and facilitators involved. The results of this review
will be used to inform the development of a framework
to help reviewers rationalise whether or not to incorpor-
ate considerations of HI in systematic reviews.
Appendix 1: Medline search strategy
OVID Medline




5 exp "Review Literature as Topic"/
6 (Cochrane adj2 review).tw.






12 (gender-based OR gender-related OR gender
differences OR gender factors).tw.
13 ((sex OR gender) adj2 (analysis OR specific OR
difference? OR factor? OR inequit$ OR disparit$ OR
inequalit$)).tw.
14 exp sex factors/
15 exp geriatrics/
16 ((ethnic$ OR race OR racial OR religio$ OR cultur$
OR minorit$ OR refugee OR indigenous OR aboriginal)
adj3 (analysis OR difference$ OR specific OR disparit$
OR inequalit$ OR inequit$)).tw.
17 exp homosexuality/
18 exp disabled persons/
19 ((poverty OR low-income OR socioeconomic$ OR
social) adj2 (analysis OR disadvantage$ OR specific OR
difference? OR factor? OR inequalit$ OR depriv$ OR
inequit$ OR disparit$)).tw.
20 exp Educational Status/
21 exp Socioeconomic Factors/
22 ((discriminat$ OR social exclu$ OR social inclu$)
adj3 (religion OR culture OR race OR racial OR aboriginal
OR indigenous OR ethnic$)).tw.
23 ((urban OR rural OR inner-city OR slum) adj2
(difference$ OR specific OR analysis OR inequit$ OR
disparit$ OR inequalit$)).tw.
24 ((resource-poor OR (low-income adj countr$) OR
(middle income adj countr$) OR africa OR developing
countr$ OR south america OR china OR asia OR latin
america) adj2 (relevance OR analysis OR specific OR
Maden Systematic Reviews  (2016) 5:202 Page 13 of 15
difference OR applicab$ OR inequit$ OR disparit$ OR
inequalit$)).tw.
25 health adj2 inequalit*.tw
26 health adj2 equit*.tw
27 health adj2 inequit*.tw
28 ((social gradient* or gap) adj3 (reduc* or difference*
or disparit* or increase* or inequit* or inequalit* or
equit* or disadvantage*)).tw
29 exp Health Status Disparities/
30 or/12-29
31 (guidance or guideline* or tool* or method* or
framework* or model*).ti.
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